Mark Hatley

9PUBLICATIONS
76CO-AUTHORS
Infant and child healthSolid tumoursHaematological tumoursGene and molecular therapyNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 13, 2026
Paediatric Therapeutic Development Workshop on rhabdomyosarcoma.

|Mar 28, 2026
Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma.

Katie E Hebron, Patience Odeniyide, Yun Wei

|Nov 15, 2023
PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors.

Madeline B Searcy, Randolph K Larsen, Bradley T Stevens

|Mar 09, 2023
Author Correction: Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia.

Jennifer L Kamens, Stephanie Nance, Cary Koss

|Feb 13, 2023
Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia.

Jennifer L Kamens, Stephanie Nance, Cary Koss

|Jul 20, 2022
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma.

Shivendra Singh, Ahmed Abu-Zaid, Hongjian Jin

Pageof 2

Frequent Collaborators

4 joint publications

Beisi Xu

3 joint publications

Taosheng Chen

3 joint publications

Junmin Peng

2 joint publications

Katherine E Gadek